Andrea Gingelmaier

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Lowered Rilpivirine Exposure During the Third Trimester of Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women.

Lowered Rilpivirine Exposure During the Third Trimester of Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 24, 2017

Prevalence of human papillomavirus infection of the anal canal in women: A prospective analysis of high-risk populations.

Prevalence of human papillomavirus infection of the anal canal in women: A prospective analysis of high-risk populations.

Journal: Oncology letters

Published: July 19, 2016

HIV, desire to have a child and pregnancy: new aspects

HIV, desire to have a child and pregnancy: new aspects

Journal: MMW Fortschritte der Medizin

Published: June 05, 2016

German-Austrian guidelines on anal dysplasia and anal cancer in HIV-positive individuals: prevention, diagnosis, and treatment.

German-Austrian guidelines on anal dysplasia and anal cancer in HIV-positive individuals: prevention, diagnosis, and treatment.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: November 28, 2015

Raltegravir in HIV-1-Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy.

Raltegravir in HIV-1-Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 31, 2015

Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women.

Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women.

Journal: The Journal of antimicrobial chemotherapy

Published: October 19, 2014

Atazanavir exposure is effective during pregnancy regardless of tenofovir use.

Atazanavir exposure is effective during pregnancy regardless of tenofovir use.

Journal: Antiviral therapy

Published: June 17, 2014

Analysis of endoplasmic reticulum stress in placentas of HIV-infected women treated with protease inhibitors.

Analysis of endoplasmic reticulum stress in placentas of HIV-infected women treated with protease inhibitors.

Journal: Reproductive toxicology (Elmsford, N.Y.)

Published: April 03, 2014

Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy: two cases.

Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy: two cases.

Journal: AIDS (London, England)

Published: January 14, 2014

National Guidelines for the prevention of mother-to-child transmission of HIV across Europe - how do countries differ?

National Guidelines for the prevention of mother-to-child transmission of HIV across Europe - how do countries differ?

Journal: European journal of public health

Published: March 13, 2013

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women.

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women.

Journal: AIDS (London, England)

Published: November 22, 2012

HIV-infection and pregnancy: what is the best form of delivery?

HIV-infection and pregnancy: what is the best form of delivery?

Journal: MMW Fortschritte der Medizin

Published: August 25, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026